Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")
Public ClinicalTrials.gov record NCT01726582. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective Phase II Trial of Molecular Profiling to Guide Neoadjuvant Therapy for Resectable and Borderline Resectable Adenocarcinoma of the Pancreas
Study identification
- NCT ID
- NCT01726582
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Medical College of Wisconsin
- Other
- Enrollment
- 229 participants
Conditions and interventions
Conditions
Interventions
- Milestone 1: Targeted chemotherapy prior to surgery Drug
- Milestone 2: Chemoradiotherapy (cXRT) Radiation
- Milestone 3: Targeted chemotherapy prior to surgery Drug
- Milestone 3: Chemoradiotherapy (cXRT) Radiation
- Milestone 4: standard FOLFIRINOX chemotherapy prior to surgery Drug
- Milestone 4: Chemoradiotherapy (cXRT) Radiation
- Milestone 5: Targeted chemotherapy after surgery Drug
- Milestone 5: Chemoradiotherapy (cXRT) Radiation
- Milestone 6: Gemcitabine after surgery Drug
- Milestone 6: Chemoradiotherapy (cXRT) Radiation
- Milestone 7: Chemoradiotherapy (cXRT) Radiation
- Milestone 8: Targeted chemotherapy after surgery Drug
- Milestone 9: Gemcitabine after surgery Drug
- Milestone 10: No additional therapy after surgery Other
Drug · Radiation · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2011
- Primary completion
- May 31, 2018
- Completion
- Apr 10, 2022
- Last update posted
- Aug 13, 2023
2011 – 2022
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Cincinnati Cancer Center | Cincinnati | Ohio | 45221 | — |
| Froedtert and The Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01726582, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 13, 2023 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01726582 live on ClinicalTrials.gov.